Gilead Sciences (GILD) Free Cash Flow (2009 - 2026)
Gilead Sciences (GILD) reported Free Cash Flow of $4.8 billion for Q3 2026, up 21.1% from $3.96 billion a year earlier and up 39.8% from the prior quarter.
Gilead Sciences (GILD) Free Cash Flow (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Gilead Sciences' Free Cash Flow came in at $13.78 billion, up 50.4% year-over-year; for FY2025, it was $9.46 billion, down 8.2% from FY2024.
- Free Cash Flow has a five-year compound annual growth rate of 4.7% (FY2020 to FY2025).
- By year, Free Cash Flow came in at $10.31 billion in FY2024 (+38.9%), $7.42 billion in FY2023 (-11.1%), $8.34 billion in FY2022 (-22.8%) and $10.81 billion in FY2021 (+43.7%).
- The Q3 2026 figure ranks as the highest quarterly Free Cash Flow since Q4 2015.
- Year over year, Free Cash Flow has now increased in each of the last four quarters, with growth averaging 54.2% over the last eight quarters.
- The high point for year-over-year Free Cash Flow in five years was Q2 2026 (growth of 376.8%); the low point was Q2 2024 (a decline of 45.7%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $3.43 billion (Q2 2026), $2.43 billion (Q1 2026) and $3.12 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -907,996.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 8.22 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 6.36 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 7.31 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 5.52 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 3.65 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 4.80 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Pfizer | 156.44 Bn | 103.79 Bn | 12.56 Bn | 4.80 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.80 Bn |
| Jun 30, 2026 | 3.43 Bn |
| Mar 31, 2026 | 2.43 Bn |
| Dec 31, 2025 | 3.12 Bn |
| Sep 30, 2025 | 3.96 Bn |
| Jun 30, 2025 | 720.00 Mn |
| Mar 31, 2025 | 1.65 Bn |
| Dec 31, 2024 | 2.83 Bn |
| Sep 30, 2024 | 4.17 Bn |
| Jun 30, 2024 | 1.20 Bn |
| Mar 31, 2024 | 2.11 Bn |
| Dec 31, 2023 | 1.95 Bn |
| Sep 30, 2023 | 1.63 Bn |
| Jun 30, 2023 | 2.20 Bn |
| Mar 31, 2023 | 1.64 Bn |
| Dec 31, 2022 | 2.39 Bn |
| Sep 30, 2022 | 2.71 Bn |
| Jun 30, 2022 | 1.66 Bn |
| Mar 31, 2022 | 1.59 Bn |
| Dec 31, 2021 | 3.05 Bn |
Gilead Sciences Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=GILD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();